Grants and Contributions:
Title:
ICAP 2023 – International Co-Innovation Action Plan
Agreement Number:
1008489
Agreement Value:
$49,720.00
Agreement Date:
Jun 1, 2023 - Nov 30, 2023
Description:
Spiderwort is a pre-clinical biomaterials company developing a novel dermal filler. We are looking for co-innovation partners who already have local credibility and networks within the dermal filler space, have an interest in innovative non-HA fillers, and have relevant regulatory approval know-how. Our goal is to enter the market via continental/central Europe (Germany/Austria) which provides access to the growing filler market with easy access to areas of Eastern Europe where filler innovation is more accepted and barriers to entry can be lower.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1Y 2C5
Reference Number:
172-2023-2024-Q2-1008489
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806788568
Recipient Type:
For-profit organization
Recipient's Operating Name:
Spiderwort Inc
Recipient's Legal Name:
SPIDERWORT Inc.
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33911